Litcius/Paper detail

Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction

Malene Kærslund Hansen, Kevin Kris Warnakula Olesen, Christine Gyldenkerne, Pernille Gro Thrane, Nina Stødkilde-Jørgensen, Martin Bødtker Mortensen, Michael Mæng

2024Journal of the American College of Cardiology11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineSemaglutideMyocardial infarctionOverweightInternal medicineCardiologyObesityDiabetes mellitusType 2 diabetesEndocrinologyLiraglutideDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerCardiovascular Function and Risk Factors
Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction | Litcius